Thomas Hartung

Thomas Hartung is the Doerenkamp-Zbinden Chair for Evidence-based Toxicology with a joint appointment in Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. He also serves as a Professor of Pharmacology and Toxicology at the University of Konstanz, Germany. As the Director of the Centers for Alternatives to Animal Testing (CAAT) at both institutions, he leads initiatives aimed at advancing non-animal testing methods and promoting evidence-based toxicology. Hartung is known for his work on the Human Toxome project, which seeks to improve toxicity testing methodologies through innovative approaches, including organoid cultures and artificial intelligence. He previously headed the European Commission’s Center for the Validation of Alternative Methods (ECVAM) and has authored over 490 scientific publications, contributing significantly to the fields of toxicology and pharmacology. His research focuses on integrating big data and AI into predictive toxicology, aiming to enhance public health outcomes through improved testing strategies.